您好,欢迎来到上海士研管理咨询有限公司
士研峰会 士研智库 士研调研
嘉宾信息
吴琼
吴琼
所属职位: 高级副总裁及首席商务官
所属公司:

上海药明巨诺生物科技有限公司

吴琼先生于2020年9月8日加入药明巨诺,担任高级副总裁兼首席商务官,全面负责公司的商业团队和商业化运营管理工作。吴琼深耕医疗健康行业26年,曾领导多个药物及器械品牌取得杰出的市场表现。加入药明巨诺之前,吴琼在默沙东中国担任医院专科业务董事总经理。此前,他还曾就职于百特中国、西安杨森等领先的医药健康企业,并取得了多项卓越成果:领导科素亚在中国市场的快速成长,使其获得市场领先地位;推动了保列治在中国市场的业绩增长,并使其成为默沙东全球市场的业绩冠军;与原国家卫生部合作,共同推动腹膜透析疗法在中国的发展,令百特中国的医院产品部扭亏为盈。吴琼拥有中欧国际工商学院高级管理人员工商管理硕士(EMBA)学位和中国药科大学药物分析专业学士学位。 Mr. Alex Wu joined JW Therapeutics on September 8, 2020, as Senior Vice President (SVP) and Chief Commercial Officer (CCO) and is in charge of the overall commercial function and operations.  Mr. Wu has been in the healthcare industry for 26 years. Before joining JW Therapeutics, Mr. Wu was an Assistant Vice President (AVP) and General Manager of Hospital Specialty Business in MSD China. Prior to that, he has worked in Baxter China, Xian Janssen, and Danone China. During his tenure, he has achieved the following outstanding results: Led the first region to launch Cozaar and made it a market leader; Accelerated the growth of Proscar in the Chinese market to surpass both UK and US markets to be the No.1 in MSD globally; Built a win-win partnership with the Ministry of Health (now known as the National Health Commission of the PRC) to promote the peritoneal dialysis (PD) therapy together in China, and turned around Baxter China’s hospital products (HP) business into a profitable and sustainable one.   

Mr. Wu received his Bachelor’s degree in Medical Analysis from China Pharmaceutical University and an EMBA (Executive Master of Business Administration) degree from China Europe International Business School (CEIBS).


微信公众号
领导者网络APP
友情链接
Copyright ©2005 - 2017上海士研管理咨询有限公司
犀牛云提供企业云服务